More evidence for the benefit of testosterone for the aging male. Note that testosterone has been shown to benefit women’s brain function and memory. ( search Testosterone and memory on my web-site for the references)

Penn Medicine, 12/08/2015

Finding comes from a study of biomedical data from patient records by Penn Medicine and Stanford researchers. Men taking androgen deprivation therapy (ADT) for prostate cancer were almost twice as likely to be diagnosed with Alzheimer’s disease in the years that followed than those who didn’t undergo the therapy, an analysis of medical records from two large hospital systems by Penn Medicine and Stanford University researchers has shown. Men with the longest durations of ADT were even more likely to be diagnosed with Alzheimer’s disease. The findings, published in the December 7 issue of the Journal of Clinical Oncology, do not prove that ADT increases the risk of Alzheimer’s disease. But the authors say they clearly point to that possibility, and are consistent with other evidence that low levels of testosterone may weaken the aging brain’s resistance to Alzheimer’s.